CoChat

Preclinical Characterization of Engineered Nanoparticles Intended for Cancer Therapeutics

Patri, Anil K., Dobrovolskaia, Marina A., Stern, Stephan T., McNeil, Scott E. · 2006 · Nanotechnology for Cancer Therapy
Cited by 41

The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.

Abstract

Ability to manipulate the biological and physicochemical properties of nanomaterial allows for more efficient drug targeting and delivery, resulting in greater potency and specificity, and decreased adverse side effects. A rational characterization strategy for biomedical nanoparticles contains three essential components: physicochemical characterization, in vitro assays, and in vivo studies. Through exquisitely targeted and multifunctional approaches, nanotechnology in particular holds great promise for enhancing cancer therapy. The biologic activity and toxicity of nanoscale particles are dependent on many parameters not typically examined for conventional small molecule therapeutics: size, shape, surface chemistry, stability of outer coating, agglomeration state, etc., and many conventional properties must be analyzed using a very different set of protocols and/or instrumentation. Specifically in cancer applications, size is an important factor in the accumulation of therapeutic nanomaterials in tumors, usually as a result of enhanced permeation and retention, caused by local defects in the vasculature and poor lymphatic drainage.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1201/9781420006636-7

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 41

Metadata

Authors
Patri, A. K., Dobrovolskaia, M. A., Stern, S. T., & McNeil, S. E.
Venue
Nanotechnology for Cancer Therapy
Publisher
CRC Press
Published
2006-12-19
Pages
105-137
OpenAlex
W2502124983
Cited by
41
References
11
FWCI
12.03
Type
book chapter
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.